RNA, 5S ribosomal pseudogene 182 (RNA5SP182)

RNA, 5S ribosomal pseudogene 182 (RNA5SP182) is an annotated human pseudogene corresponding to the 5S ribosomal RNA gene family[2]. Unlike functional 5S rRNA, which is a small RNA molecule involved in ribosome structure and faithful protein synthesis[1][3][5], RNA5SP182 does not produce a functional product. Pseudogenes such as RNA5SP182 result from duplication or retrotransposition of active genes and commonly accumulate mutations that prevent their translation or proper RNA folding[6]. While some pseudogenes have demonstrated capacity for influencing gene regulation through RNA-based mechanisms or competing for miRNA binding (decoy effect), no specific biological or clinical role has been established for RNA5SP182. It is not classified as a therapeutic target, receptor, enzyme, transporter, or any standard pharmacological target. Summary of key facts: - RNA5SP182 is a non-coding gene classified as a pseudogene. - It is not a druggable target and lacks biological function, disease role, or interactions relevant to therapeutics. - The designation in scientific databases is accurate, but it should not be listed as a receptor or pharmacological target. - There is no evidence for drug interactions, biomarker use, or safety concerns associated with RNA5SP182.

Other names

RN5S182RNA, 5S ribosomal 182RNA5SP182

None. Pseudogenes are not targeted by drugs through defined mechanisms such as inhibition, activation, or modulation, as seen with traditional drug targets[2][6].